Filing Flows › Intelligent Bio Solutions (INBS) › Q3 FY25
Intelligent Bio Solutions (INBS) Q3 FY25 earnings results (third quarter fiscal 2025)
10-Q filed May 13, 2025
Intelligent Bio Solutions (INBS) reported revenue of $902K for the third quarter fiscal 2025 (Q3 FY25), -0.6% from a year earlier and +22% from the quarter before. Operating margin was -283.8%, net loss $2.6M (282.7% of revenue).
Intelligent Bio Solutions, Q3 FY25: revenue $902K (-0.6% year over year), operating margin -283.8%, net loss $2.6M, operating cash flow −$2.8M. The chart follows the revenue to costs, profit and cash.
| Q3 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $902K | +22% | -0.6% |
| Operating profit | −$2.6M | — | — |
| Net earnings | −$2.6M | — | — |
| Operating cash flow | −$2.8M | — | — |
What changed
Revenue was $902K in Q3 FY25, down 1% year over year and up 22% from the previous quarter. Intelligent Fingerprinting Products was the largest line at 87% of revenue. Intelligent Fingerprinting Products lost $63K year over year (down 7%), 1140% of the total change.
Gross margin was 37.8%, up 18.2 points from a year earlier. Operating costs exceeded revenue by $2.6M, an operating margin of -283.8%. Operating expenses fell 7% while revenue fell 1%. The quarter ended with a net loss of $2.6M, wider than the previous quarter's $2.3M loss. Minority interests bore $7K of it: to shareholders the quarter was a loss of $2.5M.
Operating cash flow was −$2.8M. Non-cash charges added back $238K of depreciation and amortization and $12K of share-based compensation. Working capital and other items used $454K.
Questions
What was Intelligent Bio Solutions' revenue in the third quarter fiscal 2025?
Intelligent Bio Solutions (INBS) reported revenue of $902K for the third quarter fiscal 2025 (Q3 FY25), -0.6% from a year earlier and +22% from the quarter before.
Was Intelligent Bio Solutions profitable in the third quarter fiscal 2025?
Operating loss was $2.6M (-283.8% of revenue) and net loss $2.6M.